These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 4729926)

  • 21. The prognostic value of laboratory tests in liver disease.
    Tygstrup N
    Scand J Gastroenterol Suppl; 1973; 19():47-50. PubMed ID: 4123936
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of liver disease in man on the disposition of phenobarbital.
    Alvin J; McHorse T; Hoyumpa A; Bush MT; Schenker S
    J Pharmacol Exp Ther; 1975 Jan; 192(1):224-35. PubMed ID: 235636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species.
    McManus ME; Ilett KF
    Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.
    Powell LW; Axelsen E
    Gut; 1972 Sep; 13(9):690-6. PubMed ID: 4639403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiphasic testing for liver-related abnormalities in hemorrhoidal disease.
    Ganchrow MI; Bowman HE
    Surg Gynecol Obstet; 1971 Mar; 132(3):478-82. PubMed ID: 5546301
    [No Abstract]   [Full Text] [Related]  

  • 26. Clearance of antipyrine-dependence of quantitative liver function.
    Andreasen PB; Ranek L; Statland BE; Tygstrup N
    Eur J Clin Invest; 1974 Apr; 4(2):129-34. PubMed ID: 4832718
    [No Abstract]   [Full Text] [Related]  

  • 27. Liver morphology and biochemistry in eight obese patients treated with jejunoileal anastomosis.
    Juhl E; Christoffersen P; Baden H; Quaade F
    N Engl J Med; 1971 Sep; 285(10):543-7. PubMed ID: 4104638
    [No Abstract]   [Full Text] [Related]  

  • 28. Enzyme induction and renal function in man.
    Ohnhaus EE; Martin J; Kinser J; Colombo JP
    Br J Clin Pharmacol; 1977 Feb; 4(1):33-7. PubMed ID: 843422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipyrine metabolism in cancer patients.
    Higuchi T; Nakamura T; Uchino H
    Cancer; 1980 Feb; 45(3):541-4. PubMed ID: 7353204
    [No Abstract]   [Full Text] [Related]  

  • 30. Altered elimination of antipyrine in patients with acute viral hepatitis.
    Burnett DA; Barak AJ; Tuma DJ; Sorrell MF
    Gut; 1976 May; 17(5):341-4. PubMed ID: 1278717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saliva and plasma clearance of antipyrine as reflectors of liver function.
    Luoma PV; Sotaniemi EA
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial liver function studies following barium enemas containing 1 percent tannic acid.
    Harper RA; Pemberton J; Tobias JS
    Clin Radiol; 1973 Jul; 24(3):315-7. PubMed ID: 4730221
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatic coma in cirrhosis of the liver. The course and prognosis of 100 consecutive coma episodes.
    Prytz H; Sloth K
    Scand J Gastroenterol; 1973; 8(3):229-33. PubMed ID: 4724923
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver enzyme alteration: a guide for clinicians.
    Giannini EG; Testa R; Savarino V
    CMAJ; 2005 Feb; 172(3):367-79. PubMed ID: 15684121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of flurbiprofen on the metabolism of antipyrine in man.
    Chalmers IM; Bell MA; Buchanan WW
    Ann Rheum Dis; 1973 Jan; 32(1):58-61. PubMed ID: 4539857
    [No Abstract]   [Full Text] [Related]  

  • 36. Enhancement of hepatic drug metabolism by glutethimide in patients with liver disease.
    Farrell GC; Cooksley WG; Powell LW
    Eur J Clin Pharmacol; 1979 Sep; 16(2):113-7. PubMed ID: 499307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum bile acid concentrations in patients with liver disease.
    Fausa O; Gjone E
    Scand J Gastroenterol; 1976; 11(5):537-43. PubMed ID: 959769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticosteroid-induced changes in urea metabolism in patients with hepatocellular disease.
    Jones EA; Cain GD; Dickinson G
    Gastroenterology; 1972 Apr; 62(4):612-7. PubMed ID: 5020873
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum gamma glutamyl transpeptidase in hepatobiliary diseases. Comparison with alkaline phosphatase and aryl amidase].
    Schlaeger R; Schenzer R; Kattermann R
    Med Klin; 1972 Apr; 67(15):521-6. PubMed ID: 4340792
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma antipyrine half-life and hepatic microsomal antipyrine hydroxylase activity in rabbits.
    Statland BE; Astrup P; Black CH; Oxholm E
    Pharmacology; 1973; 10(6):329-37. PubMed ID: 4784365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.